Popular Weight-Loss Drugs Found To Cut Heart Attack and Stroke Risk
GLP-1 receptor agonists are showing evidence of sustained cardiovascular effects beyond their established metabolic benefits. Long-term trial data…
1 Healthcare Stock to Target This Week and 2 Facing Headwinds
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But…
FDA proposes excluding Novo, Lilly GLP-1s from compounding list
The headquarters of the U.S. Food and Drug Administration in Silver Spring, Maryland, Nov. 4, 2009. Jason Reed…
Eli Lilly (LLY) earnings Q1 2026
Eli Lilly on Thursday reported first-quarter earnings and revenue that blew past estimates and hiked its full-year sales…
Novartis CEO: Reality of Trump’s drug pricing to set in over next 18 months
Vas Narasimhan, chief executive officer of Novartis AG, during an announcement in the Roosevelt Room of the White…
New blood filtering treatment safely extends pregnancy in severe preeclampsia
Cedars-Sinai Health Sciences University investigators have developed and successfully tested a new treatment for pregnant women with severe…
Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies
Kelonia’s lead program, KLN-1010, is a potentially first-in-class lentiviral in vivo CAR-T therapy currently in Phase 1 for…
Eli Lilly to acquire cancer drug maker Kelonia in deal worth up to $7B
Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company…
Tips to help choose over-the-counter medications safely and wisely – The Irish Times
Over-the-counter (OTC) medications help people cure some simple diseases easily and without seeing a doctor. Some OTC drugs…
Large U.S. Trial Finds No Added Benefit From Combination Antibiotic to Prevent Infections After Surgery for Complex Leg Fractures
Newswise — A large multicenter clinical trial found no benefit to using two antibiotic powders — vancomycin, which…
Novo Nordisk partners with OpenAI as AI drug discovery hopes mount
People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in…
Less than 20% of patients in Japan interested in new Alzheimer’s drugs received one
Less than 20% of people who showed interest in taking new medications for Alzheimer’s disease went on to…